293 related articles for article (PubMed ID: 29131265)
1. Metformin reduces SATB2-mediated osteosarcoma stem cell-like phenotype and tumor growth via inhibition of N-cadherin/NF-kB signaling.
Xu HY; Fang W; Huang ZW; Lu JC; Wang YQ; Tang QL; Song GH; Kang Y; Zhu XJ; Zou CY; Yang HL; Shen JN; Wang J
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4516-4528. PubMed ID: 29131265
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic potential of the metabolic modulator Metformin on osteosarcoma cancer stem-like cells.
Paiva-Oliveira DI; Martins-Neves SR; Abrunhosa AJ; Fontes-Ribeiro C; Gomes CMF
Cancer Chemother Pharmacol; 2018 Jan; 81(1):49-63. PubMed ID: 29086064
[TBL] [Abstract][Full Text] [Related]
3. SATB2/β-catenin/TCF-LEF pathway induces cellular transformation by generating cancer stem cells in colorectal cancer.
Yu W; Ma Y; Shankar S; Srivastava RK
Sci Rep; 2017 Sep; 7(1):10939. PubMed ID: 28887549
[TBL] [Abstract][Full Text] [Related]
4. Cellular transformation of human mammary epithelial cells by SATB2.
Yu W; Ma Y; Ochoa AC; Shankar S; Srivastava RK
Stem Cell Res; 2017 Mar; 19():139-147. PubMed ID: 28167342
[TBL] [Abstract][Full Text] [Related]
5. Special AT-rich sequence-binding protein 2 acts as a negative regulator of stemness in colorectal cancer cells.
Li Y; Liu YH; Hu YY; Chen L; Li JM
World J Gastroenterol; 2016 Oct; 22(38):8528-8539. PubMed ID: 27784965
[TBL] [Abstract][Full Text] [Related]
6. Let-7d miRNA Shows Both Antioncogenic and Oncogenic Functions in Osteosarcoma-Derived 3AB-OS Cancer Stem Cells.
Di Fiore R; Drago-Ferrante R; Pentimalli F; Di Marzo D; Forte IM; Carlisi D; De Blasio A; Tesoriere G; Giordano A; Vento R
J Cell Physiol; 2016 Aug; 231(8):1832-41. PubMed ID: 26679758
[TBL] [Abstract][Full Text] [Related]
7. A novel antisense long non-coding RNA SATB2-AS1 overexpresses in osteosarcoma and increases cell proliferation and growth.
Liu SH; Zhu JW; Xu HH; Zhang GQ; Wang Y; Liu YM; Liang JB; Wang YX; Wu Y; Guo QF
Mol Cell Biochem; 2017 Jun; 430(1-2):47-56. PubMed ID: 28190168
[TBL] [Abstract][Full Text] [Related]
8. Metformin inhibits the proliferation, metastasis, and cancer stem-like sphere formation in osteosarcoma MG63 cells in vitro.
Chen X; Hu C; Zhang W; Shen Y; Wang J; Hu F; Yu P
Tumour Biol; 2015 Dec; 36(12):9873-83. PubMed ID: 26164004
[TBL] [Abstract][Full Text] [Related]
9. Role of SATB2 in human pancreatic cancer: Implications in transformation and a promising biomarker.
Yu W; Ma Y; Shankar S; Srivastava RK
Oncotarget; 2016 Sep; 7(36):57783-57797. PubMed ID: 27472393
[TBL] [Abstract][Full Text] [Related]
10. Dioscin inhibits stem-cell-like properties and tumor growth of osteosarcoma through Akt/GSK3/β-catenin signaling pathway.
Liu W; Zhao Z; Wang Y; Li W; Su Q; Jia Q; Zhang J; Zhang X; Shen J; Yin J
Cell Death Dis; 2018 Mar; 9(3):343. PubMed ID: 29497056
[TBL] [Abstract][Full Text] [Related]
11. SATB2 enhances migration and invasion in osteosarcoma by regulating genes involved in cytoskeletal organization.
Seong BK; Lau J; Adderley T; Kee L; Chaukos D; Pienkowska M; Malkin D; Thorner P; Irwin MS
Oncogene; 2015 Jul; 34(27):3582-92. PubMed ID: 25220418
[TBL] [Abstract][Full Text] [Related]
12. Glycogen synthase kinase-3β, NF-κB signaling, and tumorigenesis of human osteosarcoma.
Tang QL; Xie XB; Wang J; Chen Q; Han AJ; Zou CY; Yin JQ; Liu DW; Liang Y; Zhao ZQ; Yong BC; Zhang RH; Feng QS; Deng WG; Zhu XF; Zhou BP; Zeng YX; Shen JN; Kang T
J Natl Cancer Inst; 2012 May; 104(10):749-63. PubMed ID: 22534782
[TBL] [Abstract][Full Text] [Related]
13. SATB2 suppresses the progression of colorectal cancer cells via inactivation of MEK5/ERK5 signaling.
Mansour MA; Hyodo T; Ito S; Kurita K; Kokuryo T; Uehara K; Nagino M; Takahashi M; Hamaguchi M; Senga T
FEBS J; 2015 Apr; 282(8):1394-405. PubMed ID: 25662172
[TBL] [Abstract][Full Text] [Related]
14. MiR-26a inhibits stem cell-like phenotype and tumor growth of osteosarcoma by targeting Jagged1.
Lu J; Song G; Tang Q; Yin J; Zou C; Zhao Z; Xie X; Xu H; Huang G; Wang J; Lee DF; Khokha R; Yang H; Shen J
Oncogene; 2017 Jan; 36(2):231-241. PubMed ID: 27270422
[TBL] [Abstract][Full Text] [Related]
15. Metformin Suppresses Self-Renewal Ability and Tumorigenicity of Osteosarcoma Stem Cells via Reactive Oxygen Species-Mediated Apoptosis and Autophagy.
Zhao B; Luo J; Wang Y; Zhou L; Che J; Wang F; Peng S; Zhang G; Shang P
Oxid Med Cell Longev; 2019; 2019():9290728. PubMed ID: 31827709
[TBL] [Abstract][Full Text] [Related]
16. Metformin represses cancer cells via alternate pathways in N-cadherin expressing vs. N-cadherin deficient cells.
Ge R; Wang Z; Wu S; Zhuo Y; Otsetov AG; Cai C; Zhong W; Wu CL; Olumi AF
Oncotarget; 2015 Oct; 6(30):28973-87. PubMed ID: 26359363
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of KLF4 by Statins Reverses Adriamycin-Induced Metastasis and Cancer Stemness in Osteosarcoma Cells.
Li Y; Xian M; Yang B; Ying M; He Q
Stem Cell Reports; 2017 Jun; 8(6):1617-1629. PubMed ID: 28552603
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of metformin at low concentration on epithelial-mesenchymal transition of CD44(+)CD117(+) ovarian cancer stem cells.
Zhang R; Zhang P; Wang H; Hou D; Li W; Xiao G; Li C
Stem Cell Res Ther; 2015 Dec; 6():262. PubMed ID: 26718286
[TBL] [Abstract][Full Text] [Related]
19. Metformin synergistically enhances antitumor activity of histone deacetylase inhibitor trichostatin a against osteosarcoma cell line.
Duo J; Ma Y; Wang G; Han X; Zhang C
DNA Cell Biol; 2013 Apr; 32(4):156-64. PubMed ID: 23451817
[TBL] [Abstract][Full Text] [Related]
20. Special AT-rich sequence-binding protein 2 (SATB2) expression is sensitive but may not be specific for osteosarcoma as compared with other high-grade primary bone sarcomas.
Davis JL; Horvai AE
Histopathology; 2016 Jul; 69(1):84-90. PubMed ID: 26644288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
